JPMorgan International Research Enhanced Equity ETF (JIRE) is an actively managed exchange-traded fund that seeks long-term capital appreciation through a diversified portfolio of equity securities primarily from companies domiciled in foreign developed markets outside North America; it leverages insights from a global team of approximately 80 fundamental research analysts to modestly overweight undervalued stocks and underweight overvalued ones while maintaining index-like risk characteristics, including sector, region, and style neutrality relative to the MSCI EAFE Index. The fund offers exposure to large- and mid-cap stocks across sectors such as financials (25.2%), industrials (19.4%), consumer discretionary (10.0%), health care (11.3%), and information technology (9.3%), with top holdings including ASML Holding NV, AstraZeneca PLC, Shell PLC, Siemens AG, and Banco Santander SA; it features a net expense ratio of 0.24%, a 30-day SEC yield of approximately 2.68%, a portfolio P/E ratio of 16.25, and 214 holdings as of October 31, 2025. JIRE targets institutional and retail investors seeking enhanced returns from developed international equities with controlled tracking error and volatility similar to passive strategies. The fund, managed by Piera Elisa Grassi (25 years experience), Nicholas Farserotu (14 years), and Winnie Cheung (15 years), operates from J.P. Morgan Asset Management headquarters in New York and lists on NYSE Arca with assets under management of $9.12 billion. Originally launched as a mutual fund on October 28, 1992, it converted to an ETF structure on June 10, 2022, as part of J.P. Morgan Asset Management's strategic expansion of its active ETF lineup to 22 strategies, enabling broader investor access to its bottom-up research process through the efficient ETF vehicle.